3dds: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
[[Image:3dds. | [[Image:3dds.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 46: | Line 46: | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 14:07:21 2009'' | ||
Revision as of 15:07, 4 March 2009
Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261
Template:ABSTRACT PUBMED 19138846
DiseaseDisease
Known disease associated with this structure: Glycogen storage disease VI OMIM:[232700]
About this StructureAbout this Structure
3DDS is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Thomson SA, Banker P, Bickett DM, Boucheron JA, Carter HL, Clancy DC, Cooper JP, Dickerson SH, Garrido DM, Nolte RT, Peat AJ, Sheckler LR, Sparks SM, Tavares FX, Wang L, Wang TY, Weiel JE. Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1177-82. Epub 2008 Dec 25. PMID:19138846 doi:10.1016/j.bmcl.2008.12.085
Page seeded by OCA on Wed Mar 4 14:07:21 2009